Cassava Sciences Inc
NASDAQ:SAVA
Balance Sheet
Balance Sheet Decomposition
Cassava Sciences Inc
Cassava Sciences Inc
Balance Sheet
Cassava Sciences Inc
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
65
|
50
|
12
|
1
|
96
|
16
|
87
|
153
|
36
|
5
|
73
|
49
|
49
|
41
|
31
|
17
|
11
|
20
|
23
|
94
|
233
|
201
|
121
|
129
|
|
| Cash Equivalents |
65
|
50
|
12
|
1
|
96
|
16
|
87
|
153
|
36
|
5
|
73
|
49
|
49
|
41
|
31
|
17
|
11
|
20
|
23
|
94
|
233
|
201
|
121
|
129
|
|
| Short-Term Investments |
0
|
0
|
65
|
98
|
117
|
188
|
119
|
37
|
140
|
86
|
25
|
7
|
1
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
0
|
1
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
11
|
10
|
8
|
7
|
|
| Total Current Assets |
66
|
51
|
79
|
100
|
214
|
207
|
205
|
191
|
179
|
99
|
99
|
57
|
50
|
41
|
32
|
19
|
11
|
20
|
23
|
94
|
245
|
211
|
130
|
137
|
|
| PP&E Net |
2
|
2
|
2
|
2
|
2
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
23
|
22
|
21
|
|
| PP&E Gross |
2
|
2
|
2
|
2
|
2
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
23
|
22
|
21
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
68
N/A
|
53
-22%
|
81
+51%
|
101
+26%
|
216
+113%
|
209
-3%
|
208
0%
|
193
-7%
|
182
-6%
|
99
-45%
|
99
0%
|
57
-43%
|
50
-12%
|
41
-18%
|
32
-22%
|
19
-39%
|
11
-44%
|
20
+86%
|
24
+17%
|
94
+301%
|
267
+183%
|
235
-12%
|
152
-35%
|
158
+4%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
2
|
3
|
2
|
1
|
1
|
1
|
4
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
7
|
4
|
11
|
8
|
|
| Accrued Liabilities |
0
|
0
|
2
|
7
|
5
|
6
|
1
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
0
|
1
|
0
|
1
|
1
|
5
|
3
|
3
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
26
|
30
|
16
|
15
|
15
|
11
|
11
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
4
|
8
|
32
|
37
|
21
|
20
|
19
|
14
|
13
|
10
|
2
|
1
|
3
|
1
|
1
|
1
|
1
|
2
|
13
|
7
|
14
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
120
|
94
|
83
|
68
|
54
|
52
|
41
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
+24%
|
4
+29%
|
8
+95%
|
152
+1 854%
|
131
-14%
|
104
-21%
|
89
-14%
|
74
-17%
|
66
-10%
|
55
-18%
|
44
-20%
|
2
-96%
|
1
-50%
|
3
+189%
|
1
-73%
|
1
+57%
|
1
-55%
|
1
+180%
|
2
+50%
|
13
+514%
|
7
-43%
|
14
+94%
|
12
-17%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
53
|
74
|
112
|
143
|
137
|
118
|
114
|
118
|
130
|
132
|
136
|
104
|
117
|
131
|
146
|
157
|
164
|
169
|
175
|
207
|
284
|
381
|
405
|
|
| Additional Paid In Capital |
103
|
103
|
151
|
206
|
207
|
215
|
221
|
218
|
225
|
162
|
176
|
149
|
152
|
157
|
160
|
164
|
167
|
184
|
191
|
267
|
461
|
511
|
518
|
551
|
|
| Other Equity |
1
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
66
N/A
|
50
-23%
|
77
+53%
|
93
+22%
|
63
-32%
|
78
+23%
|
104
+33%
|
104
+0%
|
108
+4%
|
33
-70%
|
44
+35%
|
13
-70%
|
48
+269%
|
40
-17%
|
29
-27%
|
19
-37%
|
10
-48%
|
20
+102%
|
22
+13%
|
92
+317%
|
254
+175%
|
228
-10%
|
137
-40%
|
146
+6%
|
|
| Total Liabilities & Equity |
68
N/A
|
53
-22%
|
81
+51%
|
101
+26%
|
216
+113%
|
209
-3%
|
208
0%
|
193
-7%
|
182
-6%
|
99
-45%
|
99
0%
|
57
-43%
|
50
-12%
|
41
-18%
|
32
-22%
|
19
-39%
|
11
-44%
|
20
+86%
|
24
+17%
|
94
+301%
|
267
+183%
|
235
-12%
|
152
-35%
|
158
+4%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
4
|
4
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
17
|
22
|
35
|
40
|
42
|
42
|
48
|
|